RE:convertible debenture questionThe conversion was actioned Jan 8th... The Company is also pleased to announce that it will be giving notice to holders of its 10% unsecured convertible debentures due 2019 (the "Convertible Debentures") that such Convertible Debentures will be converted into common shares in the capital of Supreme ("Shares") on or about January 18, 2018 (the "Conversion Date"). Under the terms of the indenture relating to the Convertible Debentures, Supreme has the right at any time beginning on April 14, 2017 to convert all, but not less than all, of the principal amount and all accrued and unpaid interest of the Convertible Debentures at the conversion price set out therein if the volume weighted average price of the Shares for 15 consecutive trading days equals or exceeds $1.75. As of the date hereof, an aggregate principal amount of $17,366,000 and accrued but unpaid interest of $815,237 was outstanding. The Convertible Debentures will be converted on the Conversion Date at a rate of 769.23 Shares for each $1,000 principal amount plus accrued and unpaid interest. As a result of the conversion of the Convertible Debentures, Supreme expects to significantly lower its debt load and related interest expenses.... https://www.newswire.ca/news-releases/supreme-pharmaceuticals-inc-changes-name-to-the-supreme-cannabis-company-inc-and-announces-conversion-of-approximately-174-million-aggregate-principal-amount-of-10-unsecured-convertible-debentures-due-2019-665036153.html